A phase 2, randomized, double-blind, parallel-group, non-inferiority trial to evluate the safety and efficacy of isavuconazole with fluconazole in the treatment of uncomplicated esophageal candidiasis

Trial Profile

A phase 2, randomized, double-blind, parallel-group, non-inferiority trial to evluate the safety and efficacy of isavuconazole with fluconazole in the treatment of uncomplicated esophageal candidiasis

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2015

At a glance

  • Drugs Fluconazole (Primary) ; Isavuconazole (Primary)
  • Indications Candidiasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top